|
|
| | Ciladopa Basic information |
| Product Name: | Ciladopa | | Synonyms: | Ciladopa;2-[4-[(S)-2-(3,4-Dimethoxyphenyl)-2-hydroxyethyl]piperazin-1-yl]-2,4,6-cycloheptatrien-1-one;2,4,6-Cycloheptatrien-1-one, 2-[4-[(2S)-2-(3,4-dimethoxyphenyl)-2-hydroxyethyl]-1-piperazinyl]-;Ciladopa (free base) | | CAS: | 80109-27-9 | | MF: | C21H26N2O4 | | MW: | 370.44 | | EINECS: | | | Product Categories: | | | Mol File: | 80109-27-9.mol |  |
| | Ciladopa Chemical Properties |
| Melting point | 122-124 °C(Solv: chloroform (67-66-3); hexane (110-54-3)) | | Boiling point | 571.6±50.0 °C(Predicted) | | density | 1.213±0.06 g/cm3(Predicted) | | pka | 13.97±0.20(Predicted) |
| | Ciladopa Usage And Synthesis |
| Uses | Antiparkinsonian; dopaminergic
agent. | | Brand name | Tremerase (Wyeth-Ayerst). |
| | Ciladopa Preparation Products And Raw materials |
|